相关实验视频

Updated: Jan 18, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

下一代神经保护在玻璃眼:协同分子用于向治疗

Alessio Martucci¹, Massimo Cesareo¹, Maria Dolores Pinazo-Durán²

¹Ophthalmology Unit, Department of Experimental Medicine, University of Rome 'Tor Vergata', Montpellier 1, 00133 Rome, Italy.

Journal of clinical medicine

|September 13, 2025

概括

新兴的神经保护剂提供了一个有希望的多目标方法来减缓青光眼的进展,改善视力和生活质量. 组合疗法对视网膜质细胞 (RGCs) 和视觉功能显示出添加性益处.

科学领域:

眼科医生眼科眼科
神经科学是一个神经科学.
药理学药理学是指药理学的学科.

背景情况:

玻璃眼是一个渐进的视神经病变,导致视网膜质细胞 (RGC) 亡和视力丧失.
眼内压力 (IOP) 降低是主要的,但许多患者尽管接受治疗,但仍有进展.
神经保护剂针对的是互补的致病途径.

研究的目的:

综合目前关于青光眼神经保护的证据.
审查新兴的药物,针对眼的复杂神经生物学.
评估组合疗法在维护视力方面的潜力.

主要方法:

关于近期PubMed研究关于青光眼神经保护的文献综述.
关于神经保护剂的实验和临床数据的综合.
对诸如,CoQ10,pyruvate,nicotinamide,PQQ,homotaurine,berberine和GABA等药物的证据分析.

主要成果:

在临床前和临床研究中,单个药物如,CoQ10,pyruvate,nicotinamide,PQQ,homotaurine和berberine在临床前和临床研究中显示出有前途.
组合疗法 (例如,花素 + CoQ10 + B3) 显示了RGC电生理学,视觉功能和生活质量的增加性改善.
这些组合可以在不改变眼内压力 (IOP) 的情况下改善结果.

结论:

一种多目标的神经保护方法适用于绿眼病的复杂病理.
组合疗法可能比单一疗法更有效地减缓青光眼的进展.
需要进一步的研究来优化剂量并确认长期的安全性和有效性.

关键词:

柏柏林氨酸是一种柏柏林氨酸.这种药物有Citicoline和Citicoline.辅酶Q10是一种辅酶.加玛-氨基黄油酸 (Gamma-aminobutyric acid) 是一种胺酸.玻璃眼 glaucoma 玻璃眼玻璃眼玻璃眼玻璃眼这是一种homotaurine.神经保护神经保护尼古丁胺胺是什么尼古丁胺罗基诺因氨酸氨酸.皮鲁酸是一种

更多相关视频

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...